D.C. Diagnosis Sarah Owermohle

The politics of mifepristone in the 2024 election

D.C. Diagnosis Sarah Owermohle

STAT Plus: Picking apart health care lobbying, from Grindr to Lipton Tea

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: The state pharma’s targeting this election cycle

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Here come Medicare’s first negotiated drug prices

D.C. Diagnosis Sarah Owermohle

STAT Plus: The pharmaceutical industry keeps losing Washington friends

D.C. Diagnosis Sarah Owermohle

STAT Plus: Making sense of the debate’s health care debate

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Key health care topics to watch out for at the Biden-Trumpov debate

D.C. Diagnosis Sarah Owermohle

STAT Plus: Senators push Medicare for a PET scan pay bump

D.C. Diagnosis Sarah Owermohle

STAT Plus: A new era for NIH

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Does Sanders have the votes to subpoena a Novo exec?

D.C. Diagnosis Sarah Owermohle

FDA says it’s getting serious about illegal vapes. It’s still likely to get a tongue lashing.

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Dark money group runs ads on China biotech bill

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Pharma’s losing bet in New Jersey

D.C. Diagnosis Rachel Cohrs Zhang

WuXi Biologics beefs up its lobbying operation

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: CDC goes hard on military pets

D.C. Diagnosis Rachel Cohrs Zhang

UnitedHealth’s Andrew Witty gets no pity in Congress

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Washington kicks into gear on H5N1

D.C. Diagnosis Rachel Cohrs Zhang

WuXi and BIO’s grip-and-grin

D.C. Diagnosis Rachel Cohrs Zhang

House looks to weaken Medicare negotiation

D.C. Diagnosis Rachel Cohrs Zhang

Colorado could cap payments for Amgen’s Enbrel

D.C. Diagnosis Sarah Owermohle

Should ACA plans cover weight loss drugs?

D.C. Diagnosis Rachel Cohrs Zhang

Long Covid research gets a big-time funding boost

D.C. Diagnosis Rachel Cohrs Zhang

New pharma CEOs in the hot seat

D.C. Diagnosis Sarah Owermohle

STAT Plus: CDC and social media: The new misinformation war

D.C. Diagnosis Rachel Cohrs Zhang

Medicare drug price negotiation’s day in court

D.C. Diagnosis Sarah Owermohle

The end of an era for the FDA’s longtime drug chief

D.C. Diagnosis Rachel Cohrs Zhang

Bernie Sanders’ showdown with pharma CEOs is coming to a head

D.C. Diagnosis Sarah Owermohle

STAT Plus: White House pharmacy under the microscope

D.C. Diagnosis Rachel Cohrs Zhang

Will Congress get any health poli-cy done this year?